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A retroviral element (MSRV) defining a family of genetically inherited endogenous retroviruses (HERV-W) has recently been
characterized in cell cultures from patients with multiple sclerosis (MS). To address the possible relationship with MS, direct
detection of circulating virion RNA was proposed but revealed technically difficult to perform in standardized conditions, in
the face of multiple endogenous HERV-W copies. A parallel approach has evaluated MSRV potential pathogenicity in relation
to characteristic features of multiple sclerosis, in particular, T-lymphocyte-mediated immunopathology. We report here that
MSRV particles induce T-lymphocyte response with a bias in the Vb16 chain usage in surface receptor, whatever the HLA
DR of the donor. A recombinant MSRV envelope—but not core—protein reproduced similar nonconventional activation.
Molecular analysis of Vb CDR3 showed that Vb16 expansions are polyclonal. Our results thus provide evidence that MSRV
envelope protein can trigger an abnormal immune response with similar characteristics to that of superantigens. © 2001
Academic PressKey Words: endogenous retrovirus; MSRV; HERV-W; envelope protein; immunopathology; T-lymphocyte; T-cell receptor;
superantigen; cytokines; multiple sclerosis.INTRODUCTION
Multiple sclerosis (MS) is a multifactorial inflammatory
disease of the central nervous system characterized by
plaques of demyelination and gliosis, with lymphocytic
infiltrates and prominent T-cell activation. Epidemiologic
and clinical data suggest that both genetic and environ-
mental factors could be involved in the etiology of this
disease. One major effector of MS pathogenesis con-
sists of an autoimmune process directed against myelin
components probably triggered by environmental factors
among which viruses are favored candidates. Viruses
such as herpesviruses (Ascherio and Munch, 2000; Fer-
rante et al., 2000; Soldan et al., 1997; Wandinger et al.,
2000) and retroviruses (Haahr et al., 1991; Koprowski et
al., 1985; Perron et al., 1991b) have been suggested to be
associated with multiple sclerosis. Different groups have
detected retroviral particles in cultured cells from MS
patients (Haahr et al., 1991; Lan et al., 1994; Perron et al.,
1991b). Linking such avenues of research, transactiva-
tion of a particular retroviral element by herpesviruses in
MS has been epidemiologically (Haahr and Munch,
2000) or experimentally (Perron et al., 1993) argued.1 To whom correspondence and reprint requests should be ad-
ressed. E-mail: herve_perron@eu.biomerieux.com.
321Analyzing RNA associated with viral particles pro-
duced in MS choroid plexus or B-lymphocyte cultures,
we had identified sequences corresponding to overlap-
ping regions of a retroviral genome (Komurian-Pradel et
al., 1999; Perron et al., 1997b) that was provisionally
named MSRV (for multiple sclerosis associated retrovi-
rus element). MSRV revealed to have genetically homol-
ogous elements in human DNA defining a novel family of
human endogenous retroviruses (HERV-W) (Blond et al.,
1999), suggesting that retroviral particles could have an
endogenous origin or, more likely here, that they could
originate from a “modified” (e.g., retrotransposed and/or
recombined) or exogenous member of the same family
(Komurian-Pradel et al., 1999; Perron et al., 2000). To
address the possible relationship between this retroviral
expression and MS, direct detection of circulating virion
particles was proposed (Garson et al., 1998), but re-
vealed highly difficult to perform in standardized condi-
tions due to the existence of a multicopy HERV-W family
in human DNA (Olsson et al., 1999). A parallel approach
consisted of studying the potential pathogenicity of this
retrovirus in relation to characteristic features of this
disease, such as the abnormal lymphocyte behavior re-
sulting in autoimmunity and multifocal inflammation in
brain tissue.
In the context of a disease with severe immunolog-
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322 PERRON ET AL.ical impairment such as MS, the plausible role of a
retroviral superantigen, possibly of endogenous origin,
has been evoked from the origin of our observations
(Rasmussen et al., 1993; Rudge, 1991). The ability of
superantigens to cause antigen-independent poly-
clonal activation of any T lymphocyte with a specific
variable b chain (TCR Vb) can result in abnormal
utoreactive T-cell activation (Zhang et al., 1995) and
versecretion of proinflammatory lymphokines (Arad
t al., 2000). Thus, a retroviral expression in early MS
esions would trigger an excessive proportion of infil-
rating T lymphocytes resulting in (i) a disproportionate
nflammatory response in focal areas mediated by
ocally oversecreted cytokines; (ii) a secondary “hyper-
ctivation” of other lymphoid cells amplifying the in-
lammatory cascade; and (iii) an uncontrolled expan-
ion of autoreactive T cells bearing (or not) the tar-
eted TCR Vb motif. Consequently, such a
uperantigen could be a key factor in MS immuno-
athogenesis (Rudge, 1991).
To address this issue, we have analyzed in vitro
hether infection of human peripheral blood lympho-
ytes (PBL) from healthy donors with MSRV particles
nduced a selective Vb expansion and whether a recom-
binant MSRV protein could mimic this eventual effect.
FIG. 1. Electron microscopy: retroviral particles in MS LCLs. Electron
twice a week over 3 weeks from two MS, two non-MS patients, and one
fixed LCL cells were examined longitudinally (several hundreds of cells
cell surface in control LCLs. In MS LCLs, retrovirus particles in isolated
of RT activity. Long periods of observation were necessary for such fin
the cytoplasmic membrane in isolated cells, whereas clusters of retrov
100 nm.We report here that a significant and polyclonal acti-
vation of T cells bearing Vb16 TCR chains has repeatedlyeen found after inoculation of MSRV virions to PBLs
rom healthy donors with various HLA class II haplo-
ypes. We also report that the recombinant “Env” protein
ncoded by MSRV clones (Komurian-Pradel et al., 1999)
reproduces a similar superantigen activity to that ob-
served with virion preparations.
RESULTS
Retroviral particles from MS cultures
Virion and control pellets were always prepared and
aliquoted from the same culture material, obtained
from MS and non-MS (i) early-passage B-lymphoblas-
toid cell lines -LCL-, and, (ii) choroid plexus -CP- cul-
tures as already characterized (Perron et al., 1997a,
1991a). Supernatants were collected over 2- to 4-week
periods during which peaks of virion production were
detected in MS cultures by RT activity as previously
described (Perron et al., 1993) and by electron micros-
copy as shown in Fig. 1. Therefore, collection of large
volumes of supernatants from MS cultured cells,
pooled over 3- to 4-week periods, allowed collection of
virions produced by peak(s) over this period and fur-
copy (EM) study was performed on samples collected and processed
control LCL cultures, in parallel with RT-activity detection. Sequentially
e). No retroviral particle could be seen either in the cytoplasm or at the
) were observed at one or two different periods corresponding to peaks
Extracellular particles (B, detail of A) were observed at the surface of
e particles in vacuoles were also occasionally seen. The bar indicatesmicros
healthy
/sampl
cells (A
dings.ther concentration from the total pool by ultracentrifu-
gation in a single batch.
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323IMMUNOPATHOGENICITY OF MS RETROVIRUS ELEMENTProinflammatory cytokines in PBL cultures inoculated
with MSRV virion
We evaluated the possibility that MSRV infection
and/or expression is associated with pathogenic produc-
tion of proinflammatory cytokine. Compared kinetics of
IL-6, TNF-a, and IFN-g production in 24 and 48 PBL
ultures grown in the presence of MSRV1 or MSRV2
irion pellets, TSST-1, or PHA, are presented in Fig. 2. Il-6
howed a significant increase in MSRV1 vs MSRV2 PBL
ultures. TNF-a appeared significantly increased at 24 h
only when compared to mock controls, but only moder-
ately increased when compared to the levels obtained
with purified and concentrated bacterial TSST-1 superan-
tigen or PHA. No statistical difference could be seen in
IFN-g production, given the low levels and the elevated
tandard deviation observed.
Production of IL-6, TNF-a, and IFN-g was further tested
in the 48-h supernatants of 12 new PBL cultures inocu-
lated either with MSRV1 or with MSRV2. Unlike TNF-a
which was equally undetected at 48 h (under the thresh-
old of detection), concentration of IL-6 was significantly
greater in MSRV1 PBL cultures supernatants and was
detected with most PBL tested (10/12) production rang-
ing from 1400 to 200 pg/ml in MSRV1 and 400 to 200
g/ml in MSRV2 cultures. In these new series analyzed
t 48 h only, IFN-g production was significantly higher in
a few donors only (3/12; mean of 716 pg/ml in MSRV1,
mean of 398 pg/ml in MSRV2 cultures).
Selective bias in Vb repertoire of PBL inoculated with
MSRV viral particles
The induction of a selective bias in TCR Vb repertoire
is regarded as an intrinsic property of superantigens. To
evaluate whether MSRV induces selective expansion or
deletion of certain families of Vb T cells, we performed a
cytofluorimetric analysis of the Vb repertoire among
CD3-expressing T cells in PBL cultures from healthy
donors. Cells were cultured for 24 or 48 h with either MS
virion (MSRV1), mock-control (MSRV2), or with culture
medium (control), and labeled with CD3 mAb in parallel
with one of the antibodies directed against Vb 2, 3, 5.1, 7,
, 12, 13.1, 14, 16, 17, 21, or 22. Percentages of CD31 cells
xpressing a specific Vb were compared in the MSRV1,
SRV2, and control PBL cultures.
In preliminary evaluations, Vb repertoire of cultured
PBLs showed, when compared to either MSRV2 or me-
dium alone, that MSRV1 series displays a relative ex-
pansion of Vb16 and a decrease of Vb5.1 (not shown).
The figures correctly reflected the general proportions of
Vb families in human PBLs and observed variations in
the Vb16 population were not found with other Vb nor-
ally present in a similar proportion of T cells (e.g., Vb7).
As shown in Fig. 3 for one donor, virion (MSRV1) in-
duced a specific Vb16 expansion compared to mock-inoculated (MSRV2) cultures, whereas it did not modify
other Vb (illustrated with Vb2).
The pattern of specific expansion defined by 12 Vb
families was further calculated for eight donors with
various HLA-DR genotypes (Table 1). When compared to
controls in conditions already determined in previous
FIG. 2. Cytokine kinetics and pattern of production in PBL cultures
inoculated with MSRV virion, MSRV2 control, PHA, or TSST-1 bacterial
superantigen. IL-6, TNF-a, or IFN-g were measured in 24- and 48-h
supernatants of one donor PBL cultures stimulated with 5 mg/ml
TSST-1, 5 mg/ml PHA, MSRV1, or MSRV2.studies (Lafon et al., 1992), a significant and predominant
Vb16 expansion was observed irrespective of the DR
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324 PERRON ET AL.genotype in 75% of donors (6/8). Increase in Vb16 pop-
ulations measured at a single time point (48 h) ranged
from 31 to 315%. Moderate Vb3 or Vb12 expansions were
lso noticed in 37.5% of the donors (3/8) and Vb2, 7, 8 14,
7, or 22 in 12.5% of donors (1/8), thus probably reflecting
onor-dependent phenomenon.
Analysis of the relative size of Vb families—with a
restricted panel of 5 Vb-specific antibodies focusing on
b16 variation within a representative selection (Vb2, 7,
14, 16, and 17)—was repeated in 12 PBL cultures from
FIG. 3. Cytofluorimetric analysis: Vb16 expansion in PBL culture wit
in PBL cultures 48 h after virion inoculation (MSRV1, right) compared to
by cytofluorimetry analysis. Cells were double stained with CD3 FITC (xnew donors using a new MSRV virus preparation from
CP cultures. As shown in Table 2 (no. 2 series), Vb16
n
Texpansion was also observed irrespective of the DR
genotype, in 50% of the cultures (6/12), while Vb14 ex-
pansion was noticed once. In this last case, PBL were
depleted in Vb16 lymphocytes, down to a level represent-
ng 0.40% of the Vb16 lymphocytes in control MRSV2
culture (99.6% of depletion). In addition, these very few
Vb16 lymphocytes remaining in MSRV1 culture ex-
ressed a significantly lower level of TCR Vb16 per cell:
he mean peak channel of fluorescence decreased from
50 in MSRV2 to 130 in MSRV1 (not shown). Few do-
V virion. MSRV induces expansion of Vb16 (top) and not Vb2 (bottom)
reparation (MSRV2, left). Panels correspond to contour plots obtained
nd biotinylated anti-Vb antibody 1 PE-conjugated strepavidin (y axis).h MSRors displayed a less pronounced “depletion” of specific
CR population ranging from 30 to 50%, for Vb17, Vb2,
ic
s
M
s
M
p
1
M
i
c
p
a
p
b
s
G
t
t
p
w
a
d
V
v
s
d
A
1
a
l
I
i
c
i
m
p
t
325IMMUNOPATHOGENICITY OF MS RETROVIRUS ELEMENTand Vb14, but this was not accompanied by a decrease
n the mean peak channel of fluorescence.
A third series with new virus preparation from MS and
ontrol LCLs (Table 2, no. 3 series) was analyzed with the
ame panel of Vb-specific antibodies and showed more
frequent Vb16 depletions. All five donors reacted to
SRV1 compared to MSRV2 either by a Vb16 expan-
ion (3/5) or by a Vb16 depletion (2/5). Here again,
TABLE 1
Cytofluorimetric Analysis of Vb Variations among CD3 Cells in PBL
Cultures of Healthy Donors with Various HLA DR Haplotypes
(No. 1 series)
(No. 1)
DR Vb:2 3 5 7 8 12 13 14 16 17 21 22
2/4 1
13/8 1 1
13/14 1 1
3/12 1
3/7 1 1
3/13 1 1
4/5 1 1 1 1 1
4/4 1 1 1
% 12 37 0 13 13 37 0 12 75 12 0 12
Note. PBL cultures from eight different healthy women were analyzed
t 48 h postinoculation of MSRV particles from MS B-lymphoblatoid cell
ine (LCL, batch 1), compared to mock-preparation from non-MS LCL.
ncrease of Vb usage in MSRV1 compared to MSRV2 cultures was
determined as indicated under Materials and Methods. Only significant
variations (ranging from 131 to 1315%) are indicated with plus signs.
Bottom percentage values correspond to the percentage of donors
showing a significant Vb expansion.
TABLE 2
Cytofluorimetric Analysis of Vb Variations among CD3 Cells in PBL
Cultures of Healthy Donors with Various HLA DR Haplotypes
(No. 2 and 3 series)
(No. 2)
DR Vb:2 14 16 17
(No. 2)
DR Vb:2 14 16 17
11/13 1 1/15
4/16 2 4/11
4/4 11/13 1
3/13 1 (No. 3) DR
1/15 2 2 1 13/14 2 2
4/15 1 3/12 1 1
15/14 1 4/14 1
2/2 2 3/13 2
4/16 1 2 4/15 1
Note. No. 2 series: PBL cultures from 12 different donors, 24 h after
noculation with MSRV particles from MS choroid plexus (CP, batch 2)
ultures compared to mock-preparation from non-MS CP.
No. 3 series: PBL cultures from five different donors, 48 h after
noculation with MSRV particles from MS LCL (batch 3) compared to
ock-preparation from non-MS LCL (new batch). Only significant ex-
ansions (as in Table 1) and significant depletions (ranging from 235
o 299.5%) are indicated with plus and minus signs, respectively.SRV1 reactive cultures were not associated with a
articular HLA DR.
In these series analyzed at a single time point (Tables
and 2), three different preparations of virus (two from
S LCL, one from primary CP cultures) yielded a signif-
cant modification in the size of the Vb16 family in more
than 70% of PBL cultures.
Selective expansion of Vb16 and Vb17 expressing T
ells in PBL cultured with recombinant MSRV Env
rotein
Since retroviral proteins could be detected by FACS
nalysis in PBL cultured in the presence of MSRV virion
reparation (not shown), we have evaluated the possi-
ility that MSRV recombinant proteins could encode a
uperantigen-like activity. Recombinant MSRV Env and
ag proteins were produced in Escherichia coli and
inoculated in PBL cultures. The Vb repertoire was simi-
larly analyzed with antibodies against an appropriate Vb
panel by cytofluorimetry, after incubation with 10–100 ng
of protein per 2 3 106 cells in 1 ml of culture medium.
Antibody against Vb 2, 7, 14, 16, and 17 were tested with
hree donors for two concentrations of recombinant pro-
eins. Similar to the data obtained with MSRV virion
reparations, significant modulations were observed
ith Env protein in T lymphocytes expressing Vb16, but
lso Vb17, consisting of expansion for two of the three
onors tested, and a moderate depletion restricted to
b16 of the remaining donor (Table 3). No significant
ariation was seen with the gag protein produced in the
ame bacterial system, purified with the same proce-
ure, and tested at the same concentrations (not shown).
larger study with recombinant Env protein in PBLs from
3 donors indicated that significant Vb16 modification
occurred at 48 h postinoculation with seven donors (four
cultures with expansion and three with depletion). Given
variations observed at different times postinoculation
TABLE 3
Cytofluorimetric Analysis: Vb16 and Vb17 Expansion or Depletion
Induced by Env V14 Recombinant Protein
PBL
Donor
No.
Env V14
(ng/ml)
Vb (%)
2 7 14 16 17
12 10 13 27 7 159 151
100 9 29 8 212 156
13 10 10 4 32 230 24
100 7 2 1 24 6
14 10 80 260 ND 52 156
Note. Selective Vb expansion of healthy human PBL taken from three
different healthy women with various HLA DR, 48 h after inoculation of
MSRV Env protein or diluant as control.(not shown), a kinetic study was performed to character-
ize the dynamics of expansion/depletion induced in nor-
c
T
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326 PERRON ET AL.mal PBL by this MSRV Env protein. Though the PBL
culture presented in Fig. 4 yielded a moderate response,
it revealed (i) an early expansion of Vb16 detected at
24 h, followed by (ii) an apparent absence of effect at
48 h that obviously reflects equilibrium between expan-
sion and depletion, and finally (iii) a marked depletion at
72 h. No significant variation was observed in the other
Vb subtypes analyzed in parallel. These features are
ompatible with a superantigen-like effect targeting Vb16
CR chains. They also indicate that since Vb16 kinetics
may differ among PBL cultures, several negative (non-
FIG. 4. Cytofluorimetric analysis: kinetics of Vb16 expansion and
depletion induced by recombinant Env protein. Selective Vb expansion
of PBL from one healthy donor 24, 48, and 72 h postinoculation of MSRV
Env protein (100 ng/ml). The y axis shows relative percentage of
variation.
FIG. 5. Molecular analysis: diversity of Vb CDR3 in normal PBLs afte
represents profiles of fragments obtained by PCR using BV16 and BC
display the fluorescence intensity in arbitrary units (y axis) in the function o
calculated as described under Materials and Methods.significant) results observed in our series at a single time
point may simply reflect a “point of equilibrium” between
expansion and depletion, as observed here at 48 h in Fig.
4. Consequently, the frequency of significant Vb16 vari-
ation in previous series might be underestimated.
Molecular analysis shows polyclonality of expanded
TCR Vb16-T cells
To determine whether the modifications of CD31 T
ell expressing Vb16 correspond to oligoclonal or poly-
clonal expansions/depletions, we carried out a CDR3
spectratyping analysis (Garban et al., 2000). This tech-
nique, derived from the original description based on the
examination of CDR3 length (Pannetier et al., 1993), gives
a direct indication of the complexity of human T-cell
repertoire. Thus, unstimulated healthy donor PBLs dis-
play a highly diverse and polyclonal TCR repertoire with
a typically Gaussian distribution of CDR3 lengths. An
immune response caused by, e.g., an infection, is asso-
ciated with an oligoclonal distribution characterized by a
reduction of CDR3 profile with a unique or predominant
peak.
The comparison of Vb 16 CDR3 lengths from cells
collected 24 h after inoculation with either virion
(MRSV1), mock-virion (MRSV2), envelope recombinant
protein (Env), or medium preparation are illustrated in
Fig. 5. The profiles of the patients displaying Vb16 T-
lymphocyte expansions appear as complex and diverse
as those observed in the controls (“Gaussian-like” pro-
files with numerous peaks), thus excluding an oligo-
clonal response characterized by a sharply reduced
number of peaks (corresponding to single clones acti-
lation with MSRV virion or recombinant envelope protein. Each panel
rs labeled by a runoff using a fluorescent internal BC primer. Graphsr inocu
primef the CDR3 length (x axis). For each patient, the VB16 expansion is
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327IMMUNOPATHOGENICITY OF MS RETROVIRUS ELEMENTvated by an antigen). Similarly, in patients exhibiting a
depletion of Vb16 T lymphocytes, we observed a profile
with a polyclonal distribution of spectratypes (not
shown).
To further document that the Vb16 population from
atients inoculated with virion preparations or recombi-
ant protein is polyclonally expanded, we carried out a
efined analysis of CDR3 using a panel of seven oligo-
ucleotides specific for each of the seven BJ2 gene
egments. As shown in Fig. 6, the presence of virion or
ecombinant Env protein was associated with an in-
reased number of Vb16 peaks with variable CDR3
engths. This was observed for most of the BV-BJ com-
inations, except for BJ2.6. The latter exception is not
ncompatible with an increase in all other BJ2 segments,
ince depletion can also occur and display variable ki-
etics in individual clones. These results confirm that
hese virus- or protein-induced Vb16 variations appear
ot to result from conventional immune activation.
DISCUSSION
olyclonal activation of naive T lymphocytes
In the present study, various MSRV virion preparations
rom different cultures and corresponding Env recombi-
ant protein generated a reproducible pattern of T-lym-
hocyte activation in a series of PBL from non-MS do-
ors. This pattern was independent from donors’ HLA-DR
enotype and from culture type (EBV-immortalized B
ells or EBV-negative choroids plexus). Depending on
ulture kinetics, this activation yielded either an expan-
ion or a depletion of Vb16-bearing T lymphocytes. The
olecular analysis of the TCR b chain in Vb16 T-lympho-
yte population revealed diversity of the CDR3 and thus
onfirmed the polyclonal nature of T-cell expansion. A
arallel phenomenon was observed with Vb17 bearing T
ymphocytes but with less potent and/or less frequent
ctivation. Other occasional activations observed within
everal Vb populations were compatible with individual
FIG. 6. Molecular analysis: CDR3 length distribution in individual BJ
ength was analyzed as in Fig. 5 except that runoff was carried out wresponses varying among donors, but cannot account for
the superantigen-like effect on naive T lymphocytes. Theidentification of a recombinant MSRV envelope protein
that reproduced the biased expansions of T lymphocytes
bearing Vb16—as well as of Vb17—chain with poly-
lonal profiles strongly supports the hypothesis that this
nv protein either displays or controls the superantigen-
ike activity of MSRV. Furthermore, the Vb16 kinetics in
BL inoculated with this protein confirm the “superanti-
en-like” characteristics of this T-cell response. Further
tudies on linkage with DR and TCR molecules, as well
s with animal models, are now envisaged to define
hether, though less potent than bacterial superanti-
ens, this retroviral envelope is a superantigen stricto
ensu. Nonetheless, present data show an “abnormal”
mmune response induced by MSRV virion or Env protein
HLA-independent, Vb-specific, and polyclonal activation
of naive T cells), which should have immunopathogenic
effects similar to those described for superantigens.
TCR Vb studies in MS
Previous studies on Vb expansions in MS have re-
orted heterogeneous populations (Heard et al., 1999)
ccasionally showing moderately biased Vb usages ei-
ther in circulating autoreactive T lymphocytes (Offner and
Vandenbark, 1999) or in the general T-lymphocyte popu-
lation (Birebent et al., 1998). Different reasons can ex-
plain why biases in TCR Vb16 or 17 chains have not yet
been reported: (i) these studies used limited sets of TCR
Vb and did not mention Vb16 nor 17 analysis; (ii) locally
biased (and multifocal) expansions in brain may not be
detected in circulating lymphocytes because they are
diluted in the bloodstream or in CSF; (iii) Vb usages seen
n isolated autoreactive T-lymphocyte clones selected
fter in vitro MBP stimulation do not afford relevant
nformation about superantigen activity; (iv) the superan-
igen-induced expansion may occur during the preclini-
al phase or in early stages of the disease only and may
ecome progressively replaced by a depletion, or an
nergic status, of the T lymphocytes bearing the Vb
6 lymphocytes. PBL were incubated for 24 h with MSRV virion. CDR3
of primers corresponding to BJ2 segment 1 to 7.target; and (v) even the in situ analysis of MS plaques
may yield diverging results depending on pathologic
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328 PERRON ET AL.stage of lesions and on patient’s status. Further “ex vivo”
TCR studies might therefore be performed with classified
patient subpopulations and, importantly, should take into
account kinetics of reactivity in the time course of the
disease, including expansion, depletion, and anergy
analyses.
Biological significance
The superantigen effect reported here was detected
using a straightforward strategy based on in vitro stim-
ulation of naive T lymphocytes by virion preparations and
viral proteins. Interestingly, other studies of superantigen
activity required highly sensitive and complex tech-
niques for detecting Vb-biased stimulations, as reported
for HIV nef (Tanabe et al., 1997) or for another endoge-
nous retrovirus family, HERV-K, putatively associated
with autoimmune diabetes (Conrad et al., 1997). There-
fore, though intrinsically limited by the small percentage
of the Vb161 T-cell population in normal PBLs, our re-
ults were significant and the standard techniques we
ave used should avoid difficulties encountered with
ERV-K in autoimmune diabetes (Lapatschek et al.,
000; Lower et al., 1998). Indeed, our experimental con-
itions were previously used to state activity of well-
nown bacterial superantigens (White et al., 1989) and
iral superantigens (Lafon, 1992; Marrack, 1991). More-
ver, results from a parallel in vivo study, in which we
ave explored the pathogenicity of this retroviral element
n a humanized SCID-mouse model, support the T-lym-
hocyte-dependent pathogenicity of this retroviral ele-
ent: intraperitoneal injection of MSRV retroviral parti-
les induced brain hemorrhages that caused the death
f animals within 5–10 days postinjection, but this phe-
omenon was abolished when T lymphocytes were de-
leted in the human lymphoid cell preparation used for
CID mice engraftment (submitted manuscript).
Thus, we can assume that the observed MSRV-in-
uced effects are compatible with biological significance
nd could therefore play a role in MS disease by causing
n inflammatory process with corollary uncontrolled au-
oimmunity, which is totally disproportionate to the initial
ntigenic challenge and leads to severe tissue lesions.
hich place for this immunopathogenic retroviral
ntigen in a multifactorial disease?
From a general point of view, the results presented in
his study should provide new, but also “unifying” per-
pectives in the study of MS etiopathogenesis since their
eaning extends to all aspects of this “immunoviroge-
etic” disease. As previously evoked (Rasmussen et al.,
993; Rudge, 1991), “a retrovirally encoded superantigen”
s an ideal culprit for disimmune reactions observed in
S, all the more if encoded by a retrovirus which doesot belong to “purely exogenous” retroviruses, but to a
amily comprising endogenous retroviruses (ERVs).
l
Ienetic factors
The known genetic contribution of ERVs to (retro)viral
athogenicity (Gardner, 1990) provides an intrinsic link
ith genetic susceptibility to associated diseases. The
ontribution of particular endogenous retroviral haplo-
ypes in superantigen expression through interaction
ith exogenous strains of the same retroviral family has
een described for mouse mammary tumor virus super-
ntigen (Xu et al., 1996, 1997). Therefore, the evidence of
n immunopathogenic molecule encoded by a member
f a retroviral family comprising endogenous copies in
uman genome (HERV-W) opens corollary perspectives
n the study of MS genetic susceptibility. Interestingly,
CR Vb chain gene is present on chromosome 7q35
region and, though rather distant from the HERV-W pro-
virus present in 7q21–22 (Perron et al., 2000), abnormal
somatic rearrangements have rather frequently been re-
ported in this chromosomal region (Kere, 1989; Kere et
al., 1989a,b; Stern et al., 1989). In particular, HTLV-1
infected lymphocytes can present 7q chromosomal rear-
rangements between these regions and show impair-
ment of immune function, including loss of antigen-spe-
cific responsiveness and the acquisition of alloreactivity
(Jarrett et al., 1986; Macera et al., 1996). Endogenous
retrovirus involvement has also been reported in rear-
rangement with 7q21 locus (Wahbi et al., 1997). Conse-
quently, known HERV-W copies within MS “genetic sus-
ceptibility loci” such as HERW7q (Perron et al., 2000)
should anyway provide preliminary elements for genetic
evaluations in MS, all the more because associations
between TCRVb locus and MS have been claimed (Bri-
ant et al., 1993; Buhler et al., 2000), but also yielded
conflicting results (Wood et al., 1995).
Nonetheless, we cannot claim that this superantigen-
like activity is linked to the “normal” endogenous HERV-W
elements present in human DNA for, unless modified by
e.g., retrotransposition and/or recombination, or by inter-
action with an exogenous strain, these inherited HERV-W
elements are a priori unable to produce retroviral parti-
cles (Blond et al., 1999; Perron et al., 2000; Voisset et al.,
2000).
Infectious factors
The important contribution of infectious cofactors in
the pathogenic expression of such retroviral elements is
well known in relevant models (Contag et al., 1989; Duc
Dodon et al., 2000; Nardiello et al., 1994). A similar
contribution, as proposed in MS (Haahr et al., 1994;
Perron et al., 1993), also opens perspectives in the un-
derstanding of respective and relative roles of rather
diverse infectious agents showing various degrees of
association with MS (Perron et al., 2000). Approaches
ttempting to prove that one of them is, alone, the etio-
ogical agent of MS may therefore be inappropriate.
nterestingly, infectious agents evoked in MS studies,
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329IMMUNOPATHOGENICITY OF MS RETROVIRUS ELEMENTincluding herpesviruses (HHV6, EBV, HSV1, and VZV),
coronaviruses, and Chlamydia pneumoniae, have been
shown to transactivate latent retroviruses or viruses
(Garzino-Demo et al., 1996; Perron, 2001; Wanishsawad
t al., 2000), including MS-associated retroviral element
Perron et al., 1993).
For these reasons we now consider that the expres-
ion of such a superantigen-like molecule in MS would
onstitute a major pathogenic product of a biological
chain reaction” comprising variable infectious triggers,
argeting a common retroviral core element, and conse-
uently causing expression of pathogenic molecules
uch as retroviral superantigens (Perron, 2001; Perron et
al., 2000).
Finally, and beyond future characterization of yet un-
xplored features of this superantigen-like activity, the
ossibility of designing therapeutic molecules such as
lready described for other superantigens (Arad et al.,
2000) certainly indicates potential therapeutic perspec-
tives which could be evaluated in MS in light of our
present data, including the understanding that therapeu-
tic approaches could be combined to control each step
of such chain reaction.
MATERIALS AND METHODS
Choroid plexus cell cultures
Choroid plexus cells from two MS patients and one
control patient without neuropathological abnormalities
at autopsy were obtained from the brain-cell library (Pro-
fessor Hauw), Hoˆpital de la Salpeˆtrie`re, Paris, France. CP
cells were cultured as previously described (Perron et
al., 1991a, 1997a) with rabbit polyclonal antibody against
leukocyte-produced interferon (Sigma), at a final neutral-
izing activity of 100 U/ml in the culture fluids, added in
fresh medium at each renewal of the corresponding
culture media. These cultures were controlled by PCR for
EBV genome detection and were confirmed negative.
B-cell cultures: Lymphoblastoid cell lines
Blood from patients with definite MS—at distance
from corticoid or immunosuppressive treatments—were
obtained from Grenoble University Hospital, Neurologi-
cal Dept. (Professor Pellat). Blood from healthy controls
was obtained from the blood transfusion center (EFS) in
Lyon (Dr. Gebuhrer).
Human lymphocytes from heparinized blood diluted
1:2 with RPMI 1640 separated by Ficoll density gradient
centrifugation were collected from the buffy coat and
from occasional cellular aggregates floating underneath.
Devices with filters or separating membranes were
avoided. Cells were washed twice in RPMI 1640 and
resuspended to 2 3 106 cells/ml in RPMI 1640 with 200
U/ml penicillin, 200 mg/l streptomycin, 6 mM L-glutamin,
1% sodium pyruvate, 1% nonessential amino acid, and20% heat-inactivated fetal calf serum (FCS). The cell
flasks were incubated at 37°C and inoculated with 1 ml
(105 viral particles for 4 to 5 3 106 total lymphocytes) of
iltered supernatant from the EBV B95-8 productive cul-
ure in the presence of 200 ml (2 mg cyclosporine A for 4
to 5 3 106 total lymphocytes) of CSA (Sandoz) for 3–5
days; medium was then changed twice a week with
same medium supplemented with rabbit polyclonal an-
tibody against leukocyte-produced interferon (Sigma), at
a final neutralizing activity of 100 U/ml. Cells were kept in
the same flask until a significant number of proliferating
clones formed aggregates and were further passaged
after mechanical dissociation with a split ratio of 1:2. All
the cell lines were obtained by immortalization with the
same EBV B95-8 strain, cultured in the Dept. of Virology
(Professor Seigneurin), CHU, Grenoble. In control analy-
ses, SMRV-H (squirrel monkey retrovirus, human isolate)
sequences which can be found integrated in the B-95
EBV genome as described by Sun et al. (1995) were
searched for by PCR with two pairs of specific SMRV-H
primers in the different LCLs used in this study, as well
as in B-95 LCL used for the production of immortalizing
EBV virion. No amplification was obtained in any case,
thus excluding such retroviral contamination. Possible
HHV-6 coinfection of LCLs was also searched for by PCR
with HHV-6-specific primers (Wilborn et al., 1994), but
negative results were obtained in all cultures. The con-
stant absence of mycoplasma was confirmed in all cul-
tures with an ELISA detection kit (Roche).
RT activity
For RT activity kinetics study, 30 ml of culture super-
natants was centrifuged, first at 3000 rpm during 30 min
at 4°C to eliminate the cell debris and then at 1 h 30 min
at 35,000 rpm at 4°C. The pellets were resuspended in
100 ml Tris–HCl 0.05 M pH 8.3 and a 50-ml aliquot was
sed for the RT activity test as previously described
Perron et al., 1993). The cutoff value was calculated to
iscriminate specific activity from background signal and
epresents the mean value plus three standard devia-
ions of all points obtained from control cell lines with
dentical phenotype.
irion preparation
Virion, as well as control preparations, were similarly
repared. All culture media (obtained from LCL and CP
ultures at passages 10–20) were changed and collected
wice a week, centrifuged at 3000 rpm for 30 min, and
rozen at 280°C after addition of 10% glycerol. RT activity
as measured in culture supernatants as previously
escribed (Perron et al., 1993). Supernatants were
pooled to obtain a homogeneous preparation of about
500 ml from either an MS LCL, an MS CP, a control LCL,
or a control CP. One large volume fixed-angle rotor was
used for each homogeneous batch that was distributed
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330 PERRON ET AL.in polycarbonate tubes. Five milliliters of a “cushion”
consisting of PBS buffer with 30% glycerol was deposited
at the bottom of each tube. The supernatants were ul-
tracentrifuged at 100,000 g for 2 h and a 30-min period of
low deceleration. Pellets were collected from each
ube, resuspended in 100 ml of PBS buffer, pooled, and
ently homogenized with glycerol (10% final concentra-
ion). Pooled pellets were aliquoted (100 ml), stored at
280°C, and further used for inoculation in normal PBLs
(100 ml/2 3 106 cells). Importantly, all freezing steps used
glycerol to obtain a sufficient proportion of intact viral
particles (sucrose gradients were avoided).
Transmission electron microscopy
An amount of 107 cells was collected every week from
the LCL cultures and fixed for 30 min with 4% glutaral-
dehyde prepared in 0.2 M cacodylate buffer (pH 7.4).
Cells were rinsed three times in a solution (v/v) of caco-
dylate 0.2 M (pH 7.4) and saccharose 0.4 M, postfixed in
a solution (v/v) of 2% osmium and 0.3 M cacodylate (pH
7.4) for 30 min at 4°C, and rinsed in distilled water. For
dehydrating, cells were treated with graded ethanol se-
ries. The substitution, impregnation, and inclusion were
made in Epon for 3 days. Sections were stained with
uranyl acetate and subsequently examined with an elec-
tron microscope (Jeol 1200 EX, Tokyo, Japan).
Recombinants proteins
Recombinant MSRV proteins tested were produced in
E. coli from clone CL2 (gag/AF123881) and from clone
pV14 (env/AF331500), corresponding to cDNA clones am-
plified as previously described (Komurian-Pradel et al.,
1999). His-tagged proteins were produced and purified
by Amplicon Express (WA) and controlled by SDS–PAGE
and Western blot analyses.
PBL cultures
PBLs, used as “naive recipient cells,” were collected
from HLA-typed healthy blood donors (EFS, Lyon). PBLs
were separated from fresh blood by standard Ficoll sep-
aration procedure, counted, and frozen with adequate
stepwise protocol in decomplemented human AB serum
1 10% DMSO under two-million-cell aliquots. They were
stored in liquid nitrogen until thawed and washed in
fresh medium for the study. Cells (6 3 106) were prein-
ubated with 100 ml of virion or mock preparations for 30
min at 37°C. Cells were resuspended in RPMI with 2 mM
L-glutamine and 100 U/ml gentamicin supplemented with
0% heat-inactivated human AB serum and cultured (2 3
06 per ml) for 5, 24, or 48 h before RNA extraction or
ytofluorimetry analysis. Preincubation was omitted with
SST-1 or purified Env protein.
i
getermination of cytokines by immunocapture ELISA
Supernatants of cell culture (50 ml) and serial dilutions
of cytokine standards were incubated 2 h at room tem-
perature on ELISA plates previously blocked with 10%
FCS in PBS and coated with an mAb for cytokine capture.
Plates were washed five times with PBS–Tween. Fifty
microliters of a mixture containing biotinylated detection
Ab and streptavidin-conjugated horseradish peroxidase
was added to each well. Plates were incubated for 1 h at
room temperature. After washes with PBS–Tween, ABTS
(2,29-azino-di-[3-ethylbenthiazoline sulfonate(6)]-di-am-
monium salt crystals) substrate was added and plates
incubated at room temperature until color intensity was
maximal. OD was read at 405 nm. OD of the control cell
supernatant was subtracted and results expressed in
pg/ml.
Cytofluorimetry: Analysis of Vb repertoire
Cells were washed once with staining buffer (PBS,
.1% (w/v) sodium azide, 1% FCS, pH 7.4) and incubated
ith one of the Vb-specific biotinylated mAbs. PE-conju-
ated streptavidin was used as a second step together
ith FITC-conjugated anti-CD3 mAb. Cells were washed
n staining buffer and resuspended into “Cell fix” (Becton-
ickinson, France) and 10,000 cells of FSC and SSC
alibrated cells were analyzed by FACSCALibur cytofluo-
imeter (Becton-Dickinson). Usage of a given Vb was
expressed as a percentage of CD31 T cells. Increase or
decrease in MSRV1 cultures was determined by the
formula: ((%CD3 Vb1 cells in MSRV1 PBL culture) 2
(%CD3Vb1 cells in MSRV-PBL culture))/(%CD3Vb1 cell
in MSRV-PBL culture). Variations over 30% were signifi-
cant with this technical procedure, as previously deter-
mined (Lafon et al., 1992).
Molecular analysis of TCR polyclonality
Cells (2 3 106) were collected from a culture well,
ashed with PBS, and resuspended in 200 ml of PBS for
otal RNA extraction using the “RNA Now kit” (Biogentec).
otal RNA (0.5–1 mg) was reverse transcribed to cDNA
using the Super Script RNASE H-Reverse Transcriptase
Kit (Life Technology). PCR reactions were carried out in a
Gene Amp 9600 (Perkin–Elmer) and performed using one
of the BV subfamily primers and a BC primer as previ-
ously described for size spectratyping of TCR b CDR3
Garban et al., 2000). The PCR products were copied in
un-off reactions primed with Texas red, labeled internal
C primer, over five cycles consisting of 2 min 94°C, 2
in 60°C, and 15 min 72°C. The run-off products were
un on 6% polyacrylamide denaturing sequencing gels
sing a Vistra 725 DNA sequencer (Molecular Dynam-
cs). Fragment sizes were determined automatically us-
ng ImageQuant software (Vistra Systems) and then
raphically represented as peaks.
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